Trumps Hydroxychloroquine VS. Medias Preferred Remdesivir
Washington (Kirkland) nursing home: No hydroxychloroquine, 35 deaths out of 120 residents
— James Todaro, MD (@JamesTodaroMD) April 11, 2020
Texas nursing home: Treatment WITH hydroxychloroquine, 1 death out of 135 residents#COVIDー19 #coronavirus https://t.co/l6i4dVrC2z
Treatment options for #COVID19 in USA:
— James Todaro, MD (@JamesTodaroMD) April 12, 2020
Hydroxychloroquine:
- $0.63 per pill
- generic
- 11 US manufacturers
Azithromycin:
- $0.84 per pill
- generic
- 12 US manufacturers
Remdesivir:
- $1000 per pill
- on-patent
- 1 US manufacturer (Gilead)...
So interesting that small, non-randomized trials showing marginal benefit (68%) for Remdesivir is presented as "great hope" by the MSM, but much larger studies for Hydroxychloroquine and Azithromycin that prove 91% effectiveness mean nothing and are just "dangerous."
— Mike Coudrey (@MichaelCoudrey) April 12, 2020
Comments
Post a Comment